Mode
Text Size
Log in / Sign up
N/A N=1,600 Randomized Double-blind Prevention

Regional Versus General Anesthesia for Promoting Independence After Hip Fracture

Hip Fractures

Enrolled (actual)
1,600
Serious AEs
31.1%
Results posted
May 2024
Primary outcome: Primary: Death or Inability to Walk 10 Feet or Across a Room Without Human Assistance — 132; 132 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Regional Anesthesia (Procedure); General Anesthesia (Procedure)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
University of Pennsylvania
Primary completion
Jun 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Death or Inability to Walk 10 Feet or Across a Room Without Human Assistance
132; 132
SECONDARY
Overall Health and Disability
22.7; 18.2; 10.4; 10.4; 10.4; 8.3
SECONDARY
Ability to Return to Home
108; 114; 103; 90; 119; 116
SECONDARY
Chronic Pain
4.5; 4.2; 3.5; 3.4; 3.1; 3.2
SECONDARY
Cognitive Function
2; 2; 2; 2; 2; 2
SECONDARY
All-cause Mortality
30; 32; 69; 63; 98; 92
SECONDARY
Need for Assistive Devices for Walking
403; 397; 231; 231; 196; 193
SECONDARY
Acute Postoperative Pain
7.9; 7.6; 7.1; 7.1; 6.8; 6.6
SECONDARY
Satisfaction With Care
85; 97
SECONDARY
Postoperative Delirium
130; 124
SECONDARY
Inpatient Mortality
5; 13
SECONDARY
Major Inpatient Morbidity
98; 120

Summary

The purpose of this study is to find out if two types of standard care anesthesia are the same or if one is better for people who have hip fractures.

Eligibility Criteria

Inclusion Criteria

  • Clinically or radiographically diagnosed intracapsular or extracapsular hip fracture
  • Planned surgical treatment via hemiarthroplasty, total hip arthroplasty or appropriate fixation procedure
  • Ability to walk 10 feet or across a room without human assistance before fracture

Exclusion Criteria

  • Planned concurrent surgery not amenable to spinal anesthesia
  • Absolute contraindications to spinal anesthesia
  • Periprosthetic fracture
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02507505). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search